Eloxx Pharmaceuticals Inc., of Waltham, Mass., named Eitan Kerem as a senior consultant.
Enosi Life Sciences Corp., of San Diego, appointed James N. Woody executive chairman.
Eqrx Inc., of Cambridge, Mass., appointed Rona Anhalt chief people officer, Christian Antoni chief development officer, Eric Hedrick chief physician executive and Daniel Hoey chief of technical operations. Andrew Dillon joins as an Eqrx advisor.
Silence Therapeutics plc, of London, appointed Mark Rothera president and CEO and board member.
Starton Therapeutics Inc., of New York, appointed Keith Darragh chief financial officer.
Synlogic Inc., of Cambridge, Mass, appointed David Hava chief scientific officer.
Vyne Therapeutics Inc., of Bridgewater, N.J., appointed Patrick G. LePore to its board.